ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $202,000 | -22.9% | 66,749 | 0.0% | 0.29% | -29.8% |
| Q1 2018 | $262,000 | -5.1% | 66,749 | 0.0% | 0.41% | +122.8% |
| Q4 2017 | $276,000 | -32.7% | 66,749 | 0.0% | 0.18% | -43.0% |
| Q3 2017 | $410,000 | -1.2% | 66,749 | 0.0% | 0.32% | -1.5% |
| Q2 2017 | $415,000 | -1.9% | 66,749 | 0.0% | 0.33% | -9.1% |
| Q1 2017 | $423,000 | +18.5% | 66,749 | 0.0% | 0.36% | +36.2% |
| Q4 2016 | $357,000 | -5.1% | 66,749 | 0.0% | 0.26% | -30.1% |
| Q3 2016 | $376,000 | +2.7% | 66,749 | 0.0% | 0.38% | -0.3% |
| Q2 2016 | $366,000 | -26.1% | 66,749 | 0.0% | 0.38% | -21.0% |
| Q1 2016 | $495,000 | -29.6% | 66,749 | -21.1% | 0.48% | -19.7% |
| Q4 2015 | $703,000 | -7.9% | 84,650 | 0.0% | 0.60% | +7.5% |
| Q3 2015 | $763,000 | -24.9% | 84,650 | 0.0% | 0.56% | -4.6% |
| Q2 2015 | $1,016,000 | – | 84,650 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |